top of page
Canurta Website Images.jpg

An Integrated,
Future-Ready Platform

Canurta Therapeutics' Polykye™ Platform combines 23 global patents that create, screen and scale up novel, pharmaceutical grade polyphenols to generate validated candidates ready for clinical study.

 

Polykye™ produces a library of rare known chemical entities and new chemical entities which are screened for activity against anti-inflammatory and neuroprotective activities, streamlining both cost and development timelines 

​

“Kye” is the Akan word for “source” or “beginning”, signaling our commitment to developing breakthrough botanical drugs. 

Polykye Platform

Patented Production Methods

Our innovative production methods—including extraction, biosynthesis, seed activation and AI—ensure the highest purity and potency of therapeutic polyphenols. We use validated methods to identify, standardize, and optimize these compounds, meeting strict CMC requirements.

 

Combined with AI-driven optimization, these processes unlock the therapeutic potential of rare compounds like cannflavins A & B, creating scalable, clinically viable drugs.

Patented Production Methods | Canurta Therapeutics
AI-Driven Drug Discovery | Canurta Therapeutics

AI-Driven Drug Discovery

The PolyKye™ Platform accelerates the drug discovery process by integrating AI and bioinformatics at every stage. We generate and screen millions of molecular structures, using predictive modeling, bioactivity analysis, and Absorption, distribution, metabolism, excretion, toxicity (ADMET) screening to identify promising compounds.

 

By building a vast library of both known and novel chemical entities, we can rapidly advance compounds with potent anti-inflammatory and neuroprotective properties. AI synergy prediction ensures these molecules are fine-tuned for maximum therapeutic efficacy, minimizing side effects, and speeding them through the discovery-to-development pipeline.

Blockchain-Driven Supply Chain Compliance

Canurta integrates blockchain into its physical supply chain, establishing complete traceability that meets FDA regulations. This approach provides crucial product lifecycle information, ensuring batch-to-batch consistency and satisfying regulators, and ecosystem partners. 

 

Using blockchain-based supply chain management, Canurta offers a more innovative solution for navigating complexities associated with intellectual properties, government levels, regulations, laws, and logistics.

Blockchain for Compliance | Canurta Therapeutics
bottom of page